Product Code: GVR-4-68039-966-8
Alginate Dressing Market Growth & Trends:
The global alginate dressing market size is anticipated to reach USD 1.24 billion by 2030, registering a CAGR of 4.10% over the forecast period, according to a new report by Grand View Research, Inc. The market growth is mainly driven by the rising prevalence of chronic & acute wounds globally. For instance, as per a study by the NCBI, the prevalence rate of chronic wounds in the general population was calculated to be 2.21 per 1,000 populations in 2018. Similarly, as per Lippincot Williams & Wilkins Journals, the total prevalence rate of chronic wounds was estimated to be 16.8 per 1,000 hospital inpatients in Northern China. Thereby, impelling the industry growth. In addition, an increase in the number of traumatic accidents, such as road accidents, burn cases, gunshot wounds, etc., across the globe is expected to further boost industry growth.
For instance, according to the National Highway Traffic Safety Administration, an estimated 38,680 people died in 2020 as a result of motor vehicle crashes. This was a 7.2% increase from 2019. Moreover, as per American Burn Association, every year around 450,000 burn cases, which require medical attention, are reported in the U.S. alone.Furthermore, the industry is expected to propel post-pandemic due to an increase in the volumes of surgeries post-COVID-19. In addition, industry players are entering into various strategic alliances, such as partnerships, mergers, acquisitions, product launches, and geographic expansion. For instance, Medline Industries invested USD 1.5 billion in strengthening its domestic supply chain to meet the growing demand. These initiatives are expected to help the market grow over the forecast period.
Alginate Dressing Market Report Highlights:
- Non-antimicrobial dominated the type segment in 2021 owing to the wide availability of non-antimicrobial alginate dressings
- The chronic wounds segment dominated the application segment in 2021 due to the high geriatric population and the number of chronic disorders
- Hospitals dominated the end-use segment in 2021, whereas, the home healthcare segment is projected to grow at the fastest CAGR during the forecast period
- In 2021, North America was the dominant regional segmentdue to the presence of major industry players and favorable reimbursement policies
- Asia Pacific is expected to be the fastest-growing regional segment from 2022 to 2030 due to the increasing number of patients pool suffering from chronic and acute disorders
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Type
- 1.1.2 Application
- 1.1.3 End - Use
- 1.1.4 Regional Scope
- 1.1.5 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.2 Volume Price Analysis (Model 2)
- 1.6.2.1 Approach 2: Volume Price Analysis
- 1.8 List Of Secondary Sources
- 1.8 List Of Primary Sources
- 1.9 List Of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
Chapter 3 Alginate dressing market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 User Perspective Analysis
- 3.3.1 Consumer Behavior Analysis
- 3.3.2 Market Influencer Analysis
- 3.4 List of Key End - users
- 3.5 Market Dynamics
- 3.5.1 Market Driver Analysis
- 3.5.1.1 Upsurge In Prevalence Of Chronic And Acute Wounds
- 3.5.1.2 Increasing Number Of Surgeries
- 3.5.1.3 Rising Number Of Accidents, Trauma Cases And Burn Injuries
- 3.5.1.4 Technological Advancements
- 3.5.2 Market Restraints Analysis
- 3.5.2.1 Stringent Manufacturing Policies
- 3.5.2.2 High Cost Of Alginate Dressing Products
- 3.6 Alginate Dressing: Market Analysis Tools
- 3.6.1 Industry Analysis - Porter'S
- 3.6.2 SWOT Analysis, BY PEST
- 3.7 Impact of COVID - 19 on Market
Chapter 4 Alginate dressing market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
- 4.1 Definition and Scope
- 4.2 Type Market Share Analysis, 2021 & 2030
- 4.3 Segment Dashboard
- 4.4 Global Alginate Dressing Market, by Type, 2018 to 2030
- 4.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 4.5.1 Antimicrobial
- 4.5.1.1 Antimicrobial Market, 2018 - 2030 (USD Million)
- 4.5.2 Non - Antimicrobial
- 4.5.2.1 Non - Antimicrobial Market, 2018 - 2030 (USD Million)
Chapter 5 Alginate dressing market: Segment Analysis, By Application, 2018 - 2050 (USD Million)
- 5.1 Definition and Scope
- 5.2 Application Market Share Analysis, 2021 & 2030
- 5.3 Segment Dashboard
- 5.4 Global Alginate Dressing Market, by Application, 2018 to 2030
- 5.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
- 5.5.1 Acute Wounds
- 5.5.1.1 Acute Wounds Market, 2018 - 2050 (USD Million)
- 5.5.1.1.1 Surgical & Traumatic Wounds Market, 2018 - 2050 (USD Million)
- 5.5.1.1.2 Burns Market, 2018 - 2050 (USD Million)
- 5.5.2 Chronic wounds
- 5.5.2.1 Chronic wounds market, 2018 - 2050 (USD Million)
- 5.5.2.1.1 Diabetic foot ulcers market, 2018 - 2050 (USD Million)
- 5.5.2.1.2 Pressure ulcers market, 2018 - 2050 (USD Million)
- 5.5.2.1.3 Venous leg ulcers market, 2018 - 2050 (USD Million)
- 5.5.2.1.4 Other chronic wounds market, 2018 - 2050 (USD Million)
Chapter 6 Alginate dressing market: Segment Analysis, By End - use, 2018 - 2030 (USD Million)
- 6.1 Definition and Scope
- 6.2 End - use Market Share Analysis, 2021 & 2030
- 6.3 Segment Dashboard
- 6.4 Global Alginate Dressing Market, by End - use, 2018 to 2030
- 6.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 6.5.1 Hospitals
- 6.5.1.1 Hospitals Market, 2018 - 2030 (USD Million)
- 6.5.2 Specailty Clinics
- 6.5.2.1 Specialty Clinics Market, 2018 - 2030 (USD Million)
- 6.5.3 Home Healthcare
- 6.5.3.1 Home Healthcare Market, 2018 - 2030 (USD Million)
- 6.5.4 Others
- 6.5.4.1 Others market, 2018 - 2030 (USD Million)
Chapter 7 Alginate dressing market: Regional Market Analysis, By Application, By End - use 2018 - 2030 (USD Million)
- 7.1 Definition & Scope
- 7.2 Regional Market Share Analysis, 2021 & 2030
- 7.3 Regional Market Dashboard
- 7.4 Regional Market Snapshot
- 7.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
- 7.6 North America
- 7.6.1 North America Alginate Dressing Market, 2018 - 2030 (USD Million)
- 7.6.2 U.S.
- 7.6.2.1 U.S. Alginate Dressing Market, 2018 - 2030 (USD Million)
- 7.6.3 Canada
- 7.6.3.1 Canada Alginate Dressing Market, 2018 - 2030 (USD Million)
- 7.7 Europe
- 7.7.1 Europe Alginate Dressing Market, 2018 - 2030 (USD Million)
- 7.7.2 U.K.
- 7.7.2.1 U.K. alginate dressing market, 2018 - 2030 (USD Million)
- 7.7.3 Germany
- 7.7.3.1 Germany alginate dressing market, 2018 - 2030 (USD Million)
- 7.7.4 France
- 7.7.4.1 France alginate dressing market, 2018 - 2030 (USD Million)
- 7.7.5 Italy
- 7.7.5.1 Italy alginate dressing market, 2018 - 2030 (USD Million)
- 7.7.6 Spain
- 7.7.6.1 Spain alginate dressing market, 2018 - 2030 (USD Million)
- 7.8 Asia Pacific
- 7.8.1 Asia Pacific Alginate Dressing Market, 2018 - 2030 (USD Million)
- 7.8.2 Japan
- 7.8.2.1 Japan alginate dressing market, 2018 - 2030 (USD Million)
- 7.8.3 China
- 7.8.3.1 China (Mainland) alginate dressing market, 2018 - 2030 (USD Million)
- 7.8.4 India
- 7.8.4.1 India alginate dressing market, 2018 - 2030 (USD Million)
- 7.8.5 Australia
- 7.8.5.1 Australia alginate dressing market, 2018 - 2030 (USD Million)
- 7.8.6 South Korea
- 7.8.6.1 South Korea alginate dressing market, 2018 - 2030 (USD Million)
- 7.9 Latin America
- 7.9.1 Latin America alginate dressing market, 2018 - 2030 (USD Million)
- 7.9.2 Brazil
- 7.9.2.1 Brazil alginate dressing market, 2018 - 2030 (USD Million)
- 7.9.3 Mexico
- 7.9.3.1 Mexico alginate dressing market, 2018 - 2030 (USD Million)
- 7.9.4 Argentina
- 7.9.4.1 Argentina alginate dressing market, 2018 - 2030 (USD Million)
- 7.9.5 Colombia
- 7.9.5.1 Colombia alginate dressing market, 2018 - 2030 (USD Million)
- 7.10 MEA
- 7.10.1 MEA alginate dressing market, 2018 - 2030 (USD Million)
- 7.10.2 South Africa
- 7.10.2.1 South Africa alginate dressing market, 2018 - 2030 (USD Million)
- 7.10.3 Saudi Arabia
- 7.10.3.1 Saudi Arabia alginate dressing market, 2018 - 2030 (USD Million)
- 7.10.4 UAE
- 7.10.4.1 UAE alginate dressing market, 2018 - 2030 (USD Million)
Chapter 8 Alginate dressing market - Competitive Analysis
- 8.1 Recent Developments & Impact Analysis, by Key Market Participants
- 8.2 Company Categorization
- 8.2.1 Innovators
- 8.2.2 Market Leaders
- 8.3 Vendor Landscape
- 8.3.1 Key Company Market Share Analysis, 2021
- 8.3.2 Major Deals And Strategic Alliances
- 8.3.2.1 New Product Launch
- 8.3.2.2 Expansion
- 8.3.2.3 Acquisition
- 8.3.3 Market Entry Strategies
- 8.4 Company Profiles
- 8.4.1 CARDINAL HEALTH
- 8.4.1.1 Company overview
- 8.4.1.2 Financial performance
- 8.4.1.3 Product benchmarking
- 8.4.1.4 Strategic initiatives
- 8.4.2 SMITH & NEPHEW
- 8.4.2.1 Company overview
- 8.4.2.2 Financial performance
- 8.4.2.3 Product benchmarking
- 8.4.2.4 Strategic initiatives
- 8.4.3 3M
- 8.4.3.1 Company overview
- 8.4.3.2 Financial performance
- 8.4.3.3 Product benchmarking
- 8.4.3.4 Strategic initiatives
- 8.4.4 COLOPLAST CORP.
- 8.4.4.1 Company overview
- 8.4.4.2 Financial performance
- 8.4.4.3 Product benchmarking
- 8.4.4.4 Strategic initiatives
- 8.4.5 CONVATEC
- 8.4.5.1 Company overview
- 8.4.5.2 Financial performance
- 8.4.5.3 Product benchmarking
- 8.4.5.4 Strategic initiatives
- 8.4.6 PAUL HARTMANN AG
- 8.4.6.1 Company overview
- 8.4.6.2 Financial performance
- 8.4.6.3 Product benchmarking
- 8.4.6.4 Strategic initiatives
- 8.4.7 B. BRAUN MELSUNGEN AG
- 8.4.7.1 Company overview
- 8.4.7.2 Financial performance
- 8.4.7.3 Product benchmarking
- 8.4.7.4 Strategic initiatives
- 8.4.8 HOLLISTER INCORPORATED
- 8.4.8.1 Company overview
- 8.4.8.2 Financial performance
- 8.4.8.3 Product benchmarking
- 8.4.8.4 Strategic initiatives
- 8.4.9 MOLNLYCKE HEALTH CARE AB
- 8.4.9.1 Company overview
- 8.4.9.2 Financial performance
- 8.4.9.3 Product benchmarking
- 8.4.9.4 Strategic initiatives
- 8.4.10 MEDLINE INDUSTRIES, INC.
- 8.4.10.1 Company overview
- 8.4.10.2 Financial performance
- 8.4.10.3 Product benchmarking
- 8.4.10.4 Strategic initiatives